The post-translational methylation of a-amino groups was first discovered over 30 years ago on the bacterial ribosomal proteins L16 and L33 (refs 1, 2), but almost nothing is known about the function or enzymology of this modification. Several other bacterial and eukaryotic proteins have since been shown to be a-N-methylated 3-10 . However, the Ran guanine nucleotideexchange factor, RCC1, is the only protein for which any biological function of a-N-methylation has been identified 3,11 . Methylationdefective mutants of RCC1 have reduced affinity for DNA and cause mitotic defects 3,11 , but further characterization of this modification has been hindered by ignorance of the responsible methyltransferase. All fungal and animal N-terminally methylated proteins contain a unique N-terminal motif, Met-(Ala/Pro/Ser)-Pro-Lys, indicating that they may be targets of the same, unknown enzyme 3,12 . The initiating Met is cleaved, and the exposed a-amino group is mono-, di-or trimethylated. Here we report the discovery of the first a-N-methyltransferase, which we named N-terminal RCC1 methyltransferase (NRMT). Substrate docking and mutational analysis of RCC1 defined the NRMT recognition sequence and enabled the identification of numerous new methylation targets, including SET (also known as TAF-I or PHAPII) and the retinoblastoma protein, RB. Knockdown of NRMT recapitulates the multi-spindle phenotype seen with methylation-defective RCC1 mutants 3 , demonstrating the importance of a-N-methylation for normal bipolar spindle formation and chromosome segregation.
a, Purification scheme for RCC1 N-terminal methyltransferase. b, In vitro methylation assay (NE, nuclear extract; D, dialysed nuclear extract; FT, flow through, W, wash) showing activity elutes in the 40 and 60 mM NaP fractions. c, ELISA assay showing NRMT overexpression increases RCC1 a-N methylation. Data were analysed by two-tailed independent t tests. n 5 3-5 independent reactions per condition. Error bars represent 6 1 s.d. d, Lentiviral knockdown of NRMT in 293LT cells significantly decreases NRMT (arrowhead), di-and trimethylated RCC1, and levels of another methylated protein, later shown to be SET(*), as compared to control cells. b-catenin was the loading control. e, Expression of murine NRMT-Flag rescues RCC1 methylation levels in NRMT knockdown (KD) cells. f, In vitro methylation assays showing that immunoprecipitated Flag-NRMT methylates RCC1-His 6 (1, IP input; 2, substrate only; 3, Flag-NRMT elution; 4, Flag-NRMT elution without substrate; 5, control IP elution). g, His 6 -NRMT di-and trimethylates SPK-RCC1-His 6 and dimethylates PPK-RCC1-His 6 . h, Immunofluorescence of endogenous NRMT in HeLa cells with or without NRMT siRNA.
by Fourier transform mass spectrometry (FTMS) ( Supplementary  Fig. 2a ). This method was used because standard approaches cannot readily distinguish between trimethylation and acetylation. Depleting NRMT in 293LT cells, using lentivirus, significantly decreased methylation of endogenous RCC1, while not affecting overall RCC1 level ( Fig. 1d ). Similar results were obtained by depleting NRMT in HeLa cells using short interfering RNAs (siRNAs) ( Supplementary Fig. 3b ). Rabbit polyclonal antibodies generated against a unique C-terminal NRMT peptide confirmed effective knockdown of NRMT levels by the lentivirus and siRNAs ( Fig. 1d and Supplementary Fig. 3b ). Control virus had no effect as compared to untransfected 293LT cells ( Supplementary Fig. 3c ). Importantly, RCC1 methylation was rescued by expression of murine NRMT-Flag, which is not targeted by the human short hairpin RNA (shRNA; Fig. 1e ), confirming that offtarget effects of the RNA interference were not responsible for the loss of methylation. Together, these data conclusively prove that NRMT is the predominant a-N-methyltransferase for RCC1.
Rabbit polyclonal antibody (anti-me2-PPK (Pro-Pro-Lys)) against a methylated peptide corresponding to mouse RCC1 also detected methylation by NRMT of RCC1 possessing a Pro 2 residue ( Fig. 1g ). This Pro 2 residue is present in all mammalian species except humans and chimpanzees. RCC1 methylation activity was originally found in the nuclear extract of HeLa cells 3 and immunofluorescence of endogenous NRMT, or imaging of a NRMT-GFP (green fluorescent protein) fusion protein, showed that the enzyme is predominantly nuclear ( Fig. 1h and Supplementary Figs. 3d, e). siRNA against NRMT abolished the nuclear staining, confirming this localization pattern ( Fig. 1h ). Together, these data prove that NRMT is the authentic a-N-RCC1 methyltransferase and that it can recognize variants of the consensus sequence from different species.
The crystal structure of NRMT in complex with S-adenosylhomocysteine (SAH) was solved to 1.75 Å resolution by the Structural Genomics Consortium (PDB entry 2EX4). A large cavity opposite the SAH binding site could accommodate N-terminal peptides ( Fig. 2a ) and contains an arrangement of aromatic residues similar to those in chromodomains. We used ICM-PRO (Internal Coordinate Mechanics Professional) software to model an RCC1 N-terminal peptide (Ser-Pro-Lys-Arg-Ile-Ala) in the putative active site ( Fig. 2a ). In this model, only the first three residues (Ser-Pro-Lys) interact with NRMT. The optimum conformation positions the substrate a-NH 2 close to the SAH, in the correct orientation for methyl transfer, within 3.6 Å of the sulphur atom. The peptide Lys 4 side chain forms hydrogen bonds and electrostatic interactions with acidic residues at the lip of the active site. A stabilizing effect on Lys 4 results mainly from Asp 178 and Asp 181 (2.9 Å , and 3.4 Å from the e-NH 2 , respectively) plus a weaker effect of Ser 183 ( Fig. 2b) . A similar structural motif was reported previously to coordinate lysine residues 17 . Other peptides, with Pro 2 or Ala 2, adopt the same conformation (data not shown); however, substitution of Lys 4 by Gln prevented interactions with the basic residues at the lip of the active site ( Fig. 2c) .
To test the requirement for Lys 4 in substrate binding to NRMT, we measured its affinity, by isothermal titration calorimetry, for wild-type RCC1 N-terminal peptide and a mutant peptide in which Gln replaced Lys 4. Wild-type peptide showed exothermic binding to NRMT (DH 5 29.8 kcal mol 21 , K d 5 70 mM), whereas RCC1(Gln 4) did not bind detectably ( Fig. 2e ). Lys 4 is, therefore, an essential determinant of NRMT substrate specificity. In vitro methylation assays confirmed that only the wild-type peptide can be methylated by recombinant NRMT ( Supplementary Fig. 3f ). A second key interaction involves H-bonding between the Pro 3 carbonyl and the Asn 169 amido group (Fig. 2b ). NRMT(Lys 169) had no activity ( Fig. 2d ), whereas mutation of Asp 168, which does not interact with the peptide substrate, had no effect on methylation ( Fig. 2d ). Mutating residues (Asp 178, Asp 181) at the lip of the active site to Ala decreased enzyme activity, which was further decreased by reverse-charge mutagenesis to Lys (Fig. 2d ). Mutating Ser 183 to Lys also decreased activity ( Fig. 2d ). Together, these data strongly support the model for substrate binding predicted from the structure and docking analysis.
We found previously that a-N-methylation occurred on RCC1 containing Ser 2, Pro 2 or Ala 2 (ref. 3). To extend this analysis, we mutated the second residue to each of the other 17 amino acids, using a system in which Factor X cleavage provides efficient exposure of this residue. Testing the cleaved proteins for methylation revealed the enzyme to be promiscuous. Only acidic residues, some hydrophobic residues, and Trp gave no detectable methylation ( Fig. 3a) . Downstream of the x-Pro-Lys motif, mutagenesis had variable effects, but did not abolish methylation by NRMT (data not shown). We conclude that the x-Pro-Lys motif is importantforrecognitionby NRMT,butthatsubstratespecificityis likely also controlled by the efficiency with which the initiating Met is cleaved.
Using Met-(Ala/Ser/Pro)-Pro-Lys, we searched GenBank for candidate substrates of NRMT. More than 35 annotated genes contain this N-terminal motif ( Supplementary Table 1 ). To screen tissues for a-N-methylated proteins, we immunoblotted mouse tissue lysates with our anti-me3-SPK and anti-me2-PPK antibodies. In addition to RCC1, the immunoblots picked up .10 other proteins (Supplementary Fig. 4a ). All tissues contained RCC1 N-methylation activity ( Supplementary Fig. 4b ). To validate the GenBank search, we checked if any proteins detected by the antibodies corresponded to predicted substrates. Proteins were precipitated from HeLa cell lysates using anti-me3-SPK and separated by SDS-polyacrylamide gel electrophoresis. Besides RCC1 and antibody chains, one additional band was visible at a size also detected by immunoblotting ( Fig. 3b ). This band was identified by MS as SET (also known as TAF-I or PHAP-II), a predicted substrate for NRMT (Supplementary Table 1 ). SET has two splice variants, a and b. Only SETa begins with the NRMT consensus. When C-terminally tagged SETa-GFP and SETb-GFP were expressed in HeLa cells, only SETa was recognized by anti-me3-SPK ( Fig. 3c ). In addition, SETa-Flag was expressed in Hela cells, immunoprecipitated, and analysed by MS. The protein was 96.5% trimethylated on its N-terminal Ser ( Fig. 3d and Supplementary   Fig. 2b ). Similar to RCC1 (ref.
3), SETa-Flag with a Gln 4 mutation was mostly unmodified, with only 4% mono-methylation, further confirming the importance of Lys 4 ( Fig. 3d ). Finally, a band corresponding to methylated SET was reduced in cells expressing shRNA or siRNA against NRMT ( Fig. 1d and Supplementary Fig. 3b ).
We next used the anti-me3-SPK antibody, cross-linked to Protein A/G agarose, to immunoprecipitate proteins from mouse spleen and cardiac lysates. Multiple methylated bands were detected (Fig. 3e) , and six N-terminally methylated proteins were identified by MS ( Fig. 3f and Supplementary Fig. 5 ). Two, RCC1 and SET, confirm the validity of the approach (Supplementary Fig. 6 ). The other fourkelch-like protein 31 (ref. 18 ; Supplementary Fig. 4c ), ribosomal protein L23a, myosin light chain 2 and myosin light chain 3 (Supplementary Figs. 7 and 8)-confirm the predictive power of the identified motif, and expand the verified NRMT substrates.
Among the predicted substrates was the tumour suppressor protein RB. Given the importance of this protein in cell cycle control, we checked whether it too is a bona fide NRMT substrate. First, recombinant NRMT was able to methylate the N-terminal tails of both SETa and RB in vitro ( Fig. 3g ). Second, endogenous RB immunoprecipitated from the colon cancer line HCT116, which has high levels of functional RB 19 , was recognized by anti-me2-PPK ( Fig. 3h ). Third, when NRMT was depleted from HCT116 cells, RB methylation was substantially reduced ( Fig. 3h and Supplementary Fig. 3g ). LETTERS Surprisingly, RB from HeLa cells, which is inactivated by the E7 oncoprotein 20,21 , was not methylated (Fig. 3h) , even though HeLa cells express NRMT and contain methylated RCC1 and SET.
Non-methylatable mutants of RCC1 are defective in chromatin association, and their expression in a wild-type background produces supernumerary spindle poles and mis-segregation of mitotic chromosomes, most likely due to the disruption of the Ran gradient 3, 11 . To test directly the importance of RCC1 a-N-methylation for its function, we used stably silenced NRMT expression in 293LT cells (Fig. 1d) , and examined the distribution of RCC1 during mitosis. RCC1 was significantly more diffuse in mitotic cells lacking NRMT than in control cells (Fig. 4a) . The mean chromatin/cytoplasm intensity ratio of RCC1 immunofluorescence was ,twofold greater in the control cells (Fig. 4a) . This redistribution could also be observed in living 293LT cells depleted of NRMT and expressing RCC1-RFP (Fig. 4b) .
Strikingly, NRMT-depleted 293LT cells in mitosis exhibited .threefold more supernumerary spindles than the control (Fig. 4c) . These data, together with our previous studies 3 , show that one essential role for methylation of RCC1 is to stabilize chromatin association, and that this association is necessary for proper mitotic division. However, neither silencing of NRMT nor mutation of the methylation motif significantly altered RB nuclear localization or intranuclear dynamics in HCT116 cells ( Supplementary Fig. 9 ), indicating that the function of the a-N-methylation is not solely to stabilize chromatin associations, but may have a more general role in the regulation of electrostatic interactions.
This study identifies the long-sought eukaryotic a-N-methyltransferase as a conserved member of a superfamily of non-SET domain enzymes and verifies six new protein targets. It is likely that NRMT orthologues throughout the Eukarya possess the same specificity and function, because recent screens have detected N-terminal dimethylation of the Arabidopsis and yeast L12 proteins, which possess the same NRMT consensus motif (PPK) as is found in almost all other eukaryotes 5, 22 . Further analysis of L12 and other target proteins will likely reveal multiple functions for a-N-methylation. Note added in proof: While this paper was in press, the yeast N-terminal methyltransferase was identified (K. J. Webb, R. S. Lipson, Q. Al-Hadid, J. P. Whitelegge & S. G. Clarke Biochemistry 49, 5225-5235; 2010).
METHODS SUMMARY
In vitro methylation assays. Substrate proteins were expressed with C-terminal His 6 tags, and assayed in 50 mM Tris, 50 mM potassium acetate, pH 8.0, with 100 mM SAM as the methyl donor. All reactions were incubated 1 h at 30 uC and analysed for methylation by immunoblot. For ELISA assays, substrates and enzyme were mixed with 0.55 mCi 3 H-S-adenosyl-L-methionine (SAM). Reactions were incubated as above then transferred to Protein A-coated ELISA plates pretreated with anti-me2-SPK. After 1 h, the reaction was removed and wells were treated with 1% SDS for 30 min. This solution was then quantified for incorporated 3 Hmethyl by scintillation counting. Screening mutant NRMT substrates. Efficient removal of the initiating Met is dependent on the identity of the second residue. To avoid this problem, we created fusions from residues 2-10 of RCC1 with His 6 -tag plus Factor X cleavage site at the N terminus, and C-terminal GFP. Cleavage with Factor X exposes the second residue of the RCC1 N terminus. Substrate proteins containing all possible amino acids at residue 2 were expressed in Escherichia coli and purified on Ni-NTA beads, then cleaved using Factor X. LC-MS/MS identification of novel NRMT substrates. On-bead endoproteinase Glu-C and Asp-N digestions were used to identify the immunoprecipitated proteins. The retained N termini were then eluted from the beads and analysed for methylation ( Supplementary Fig. 5 ).
METHODS
Constructs and antibodies. All RCC1 constructs were as previously described 3 . Wild-type and K4Q mutant SET vectors were designed as for the RCC1 vectors but using human SET cDNA. The human RB1 ORF (Open Biosystems) was amplified to introduce a 59 HindIII restriction site, C-terminal Flag tag and 39 BamHI site, and subcloned into the mammalian expression vector pRK7. The human NRMT ORF (Open Biosystems) was amplified to introduce a 59 XbaI restriction site, C-terminal Flag tag and 39 EcoRI site, and subcloned into pRK7. The Flag tag was alternatively included in the 59 primer to create the N-terminally tagged NRMT. NRMT was also cloned into the XbaI and BamHI sites of pKGFP2, and into the NdeI and XhoI sites of pET30a to produce NRMT-His 6 . All His 6 proteins were purified as previously 24 .
Rabbit anti-me2-SPK and anti-me3-SPK antibodies were as described previously 3 . They were used in immunoblots at 1:5,000 and 1:10,000 dilutions, respectively. Rabbit anti-me2-PPK antibody was produced against 2me-P-P-K-R-I-A-K-R-R-S-C synthesized by American Peptide. Rabbit anti-NRMT was produced against the C-terminal C-R-Q-E-N-L-P-D-E-I-Y-H-V-Y-S peptide synthesized by GenScript. This peptide sequence is common to human, mouse and dog. Both peptides were coupled to activated keyhole limpet haemocyanin, and antisera were produced by Cocalico Biologicals. Anti-me2-PPK was purified as described for the anti-me2-SPK and anti-me3-SPK antisera, to remove antibodies against non-methylated peptide 3 . Both antibodies were diluted 1:1,000 for immunoblots. The following antibodies were also used for immunoblots: mouse anti-RB1 (1:2,000, Cell Signaling Technology), mouse anti-Flag M2-horseradish peroxidase (1:1,000 Sigma-Aldrich), mouse anti-b-catenin (1:3,000 BD Biosciences), and rabbit anti-GFP (1:1,000 Invitrogen).
In vitro methylation assays. To assay column fractions, 50 ml samples were buffer-exchanged into MTase buffer (50 mM Tris, 50 mM potassium acetate, pH 8.0) using Centri Spin columns (Princeton Separations). His 6 -RCC1 (1 mg) was added as substrate and 100 mM SAM was added as the methyl donor. For assays on immunoprecipitates, Flag-NRMT was eluted from M2 agarose (Sigma) in MTase buffer with 0.1 mg ml 21 Flag peptide, then His 6 -RCC1 and SAM were added as above. For testing recombinant NRMT activity, 0.3 mg His 6 -NRMT was mixed with same amounts of RCC1-His 6 and SAM and brought to 50 ml with MTase buffer. All reactions were incubated 1 h at 30 uC and analysed for methylation by immunoblot.
For ELISA methylation assays, HEK 293LT cells were calcium phosphatetransfected with 6 mg pKVenus, NRMT-pCMV-SPORT6, or Flag-NRMT. Cells were harvested 24 h post-transfection and used to make nuclear extract 25 . Nuclear extract (10 mg) was mixed with 1 mg RCC1-His 6 and 0.55 mCi 3 H-SAM and brought to 50 ml with MTase buffer. Reactions were incubated 1 h at 30 uC and transferred to Pierce Protein A-coated ELISA plates (Thermo Scientific) pretreated with 1:200 anti-me2-SPK. After 1 h, the reaction was removed and wells were treated with 1% SDS for 30 min. This solution was then quantified for incorporated 3 H-methyl by scintillation counting. Expression, purification and Factor X digestion of XPK-EGFP mutant substrates. XPK-EGFP substrate proteins were expressed from a modified pET15b (Novagen) expression vector in BL21 E. coli and purified on Ni-NTA beads, then cleaved using Factor X (Sigma-Aldrich). Reactions (50 ml) were performed in MTase buffer, using 3.0 pmol of recombinant NRMT plus 120 pmol of XPK-EGFP. The reaction was started by addition of 1 ml of 3 H-SAM (0.55 mCi ml 21 ), and incubated for 2 h at 30 uC. Reactions were filtered through nitrocellulose, washed with 50 mM sodium bicarbonate and subjected to scintillation counting. Mass spectrometry. For in-solution enzymatic digestion, active and adjacent non-active HAP fractions were dried, and reconstituted in 100 mM ammonium bicarbonate (Sigma-Aldrich). The sample was reduced, alkylated and digested with trypsin (Promega) at an enzyme:protein ratio of 1:20 at 37 uC for 6 h (ref. 26) . For in-gel enzymatic digestion, Coomassie-stained SETa-Flag bands were excised and subjected to in-gel digestion as described previously 27 , with slight modification. Gel pieces were incubated with endoproteinase GluC (Roche) overnight at room temperature followed by peptide extraction. Extracted peptides were dried by using a SpeedVac concentrator (Savant Instruments), resuspended in 0.1% glacial acetic acid, and stored at 235 uC until analysis. For both methods, an aliquot of peptide solution was loaded onto a capillary precolumn (360-mm outer diameter, 75-mm inner diameter) packed with irregular C18 packing material (5220 mm) 26, 28 . The precolumn was washed with 0.1% acetic acid and then connected with Teflon tubing to an analytical column packed with regular C18 packing material (5 mm) and a 5-mm emitter tip 26, 28 . Samples were analysed by nanoflow HPLC-microelectrospray ionization on a linear quadrupole ion trap-Fourier transform mass spectrometer (LTQ-FT; Thermo Electron) 29 . GluCdigested SETa-Flag was also analysed using a Thermo LTQ instrument modified for electron transfer dissociation (ETD) (90 ms ETD reaction) for adequate tandem mass spectrometry (MS/MS) 30, 31 . All spectra were interpreted manually.
For analysis of the tissue immunoprecipitations, while still on beads, the purified proteins were reduced and carbamidomethylated on Cys residues and half of each was proteolytically digested in 100 mM ammonium bicarbonate (pH 8) using either endoproteinase Asp-N or Glu-C (Roche) for 6 h at room temperature as similarly described 27 . Following digestion, the generated peptides were removed from the N-terminal peptides still associated with the anti-me antibody on the agarose beads and later acidified to pH 3.5 using glacial acetic acid. An aliquot of the endoproteinase Asp-N-and Glu-C-generated peptides were pressure-loaded onto an irregular C18 (6 cm in length, 5-20 mm diameter, 120 Å pore size, YMC) capillary precolumn (360-mm outer diameter, 75-mm inner diameter) and washed with 0.1% acetic acid (Sigma Aldrich) before connecting the precolumn to a C18 (8 cm in length, 5 mm diameter, 120 Å pore size, YMC) analytical capillary column (360-mm outer diameter, 50-mm inner diameter) equipped with an electrospray emitter tip as described 26, 28 . Digested samples were gradient-eluted for mass analysis at a flow rate of 60 nl min 21 using nanoflow HPLC and electrospray ionization into a linear ion trap and Fourier transform hybrid mass spectrometer (LTQ-FTMS or LTQ-Orbitrap, Thermo Scientific) as described above. Mass spectrometers used were front end ETD (FETD)-enabled to allow both CAD and ETD analyses for each digested sample in addition to high resolution precursor mass measurements. Mass analyses were completed with one high resolution (60,000 resolution at 400 m/z) MS1 scan followed by 8-10 CAD or ETD data-dependent MS2 scans. For ETD experiments, MS2 parameters were set as follows: 35 ms reaction time, 3 m/z precursor isolation window, charge state rejection 'on' for 11 and 12 charge state precursor ions, 2 3 10 5 FTMS full AGC target, 1 3 10 4 ITMS AGC target, 2 3 10 5 reagent target with azulene as the electron transfer reagent. All data were searched using the Open Mass Spectrometry Search Algorithm (OMSSA) against the entire mouse RefSeq database (downloaded June 2009) followed by manual confirmation.
To reduce the number of sample analyses, the separated bead aliquots from each digest were recombined for N-terminally modified peptide analyses. Peptides resulting from the Asp-N/Glu-C digests yet still retained on agarose beads were placed on a spin column (Thermo Scientific) washed with two 20 ml aliquots of Elution Buffer pH 2.8 (Pierce Crosslink Immunoprecipitation kit, Thermo Scientific) and centrifuged at 3,000g for 2 min to elute the newly released N-terminal peptides through the molecular weight cutoff filter. N-terminal peptides were reconstituted in 0.1% acetic acid, loaded and mass analysed as described above. However, a top 5 data-dependent CAD/ETD MS2 toggle instrument method was implemented. All data were search using OMSSA and all N-terminally modified peptides were verified by manual confirmation. siRNA and lentiviral knockdowns. HeLa and HEK 293LT cells were grown in DMEM supplemented with 5% calf serum and 5% FCS, 100 U ml 21 penicillin and 100 U ml 21 streptomycin (GIBCO). HCT116 cells were grown in McCoy's 5A Medium supplemented with 5% calf serum and 5% FCS, 100 U ml 21 penicillin and 100 U ml 21 streptomycin (Quality Biologicals). Control, human RCC1 and human NRMT siRNA SMARTpools were obtained from Thermo Scientific. The sequences of the RCC1 SMARTpool were described previously 11 . Sequences of the NRMT SMARTpool are: GCAAGAGGGUGAGGAACUA, GGAAGUUU CUGCAGAGGUU, GCCAAGACCUACUGGAAAC and UAGAAGACGAGA AGCAAUU. Hela cells were transferred to antibiotic-free medium for 24 h, then transfected with siRNA SMARTpools using the Oligofectamine protocol from Invitrogen, with 180 pmol of siRNA per 35 mm plate. Cells were harvested after 72 h and analysed by immunoblot.
The human and mouse NRMT lentiviral shRNAmir pGIPZ constructs were obtained from Open Biosystems and grown and purified according to their protocol. The targeting sequence of the shRNA against NRMT is AGAGAA GCAATTCTATTCCAAG; and the control sequence is CCCTGCCAGACAG TACCAATTA. To make virus, 2.5 3 10 6 293LT cells were calcium-phosphatetransfected with 20 mg of the NRMT pGIPZ plasmid, 6 mg of the vesicular stomatitis virus coat protein plasmid (pMD2G), and 15 mg of packaging plasmid (psPAX2). Viral supernatants were collected after 48 h, concentrated with 100K ultrafilters (Millipore) and titred in 293LT cells. 293LT or HCT116 cells (2 3 10 4 ) were then infected with virus to a multiplicity of infection (m.o.i.) of 1 or 5. After 3 days, 2 mg ml 21 puromycin was added, to select for transduced cells, and surviving cells were maintained in the same medium. For the rescue, 10,000 293LT cells were infected with lentivirus (control, NRMT shRNAmir, or NRMT shRNAmir co-expressing murine NRMT-Flag) to an m.o.i. of 3. The cells were grown for 2 days and lentivector-expressing cells were selected by addition of 2 mg ml 21 puromycin. The cells were grown two additional days and lysed (500 mM NaCl; 50 mM Tris pH 8.0; 5 mM MgCl 2 ; 1 mM EDTA; 1 mM EGTA; 0.1% NP-40; BME and protease inhibitors). Each lysate (50 mg) was analysed by western blot. SPK peptide docking analysis. ICM-PRO software (Molsoft LLC) was used for docking of the model substrate peptide SPKRIA to NRMT 32 . A rigid ICM model
